Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Ranitidine’s US Future In Limbo As Tests Continue; ‘Glow-Boosting’ Mask Also Among Recent Recalls

Mar 09 2020

• By Malcolm Spicer

Product Recall - Image

Related Content

US FDA Finds Zantac Poses Little Risk, But Concerns Linger

Nov 04 2019

HBW Market Roundup: Expo West Postponed, FDA Needs International Cosmetics Meeting Input, More

Mar 03 2020

Shuttered US Supplement Firm Meets Recall Deadline, But Schumer Says FDA Late Cleaning Up Industry

Jan 24 2020

No To Grapefruit Mask? Natural Player Yes To, Inc. Issues Recall Following ‘Chemical Burn’ Reports

Jan 21 2020

Contamination In Common OTC Antacid Adds To FDA's API Impurity Concerns

Sep 15 2019

Related Companies

Cencora, Inc

Sanofi

CVS Health Corp.

Walgreens Boots Alliance Inc.

Additional Topics

Canada United States US States OTC Drugs Recalls Advertising, Marketing & Sales Commercial Companies Compliance Dietary Supplements Distribution E-Commerce Enforcement FDA Cosmetics Ingredients Manufacturing Policy Regulation Safety Consumer

More from Recalls

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.